RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

2 hedge funds and large institutions have $1.98M invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 216 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.6M
Puts
$51.5M
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SO
151
STRS Ohio
Ohio
SACTSONJ
152
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
WMSA
153
Weiss Multi-Strategy Advisers
New York
LPL Financial
154
LPL Financial
California
MFS
155
Mirabella Financial Services
United Kingdom
BC
156
BIT Capital
Germany
BOH
157
Bank of Hawaii
Hawaii
AB
158
Amalgamated Bank
New York
Commonwealth Equity Services
159
Commonwealth Equity Services
Massachusetts
VF
160
Virtu Financial
New York
Connor, Clark & Lunn Investment Management (CC&L)
161
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
Zurich Cantonal Bank
162
Zurich Cantonal Bank
Switzerland
PNC Financial Services Group
163
PNC Financial Services Group
Pennsylvania
AIM
164
Aigen Investment Management
New York
AWM
165
Avior Wealth Management
Nebraska
EFM
166
E Fund Management
China
BAM
167
Blueshift Asset Management
New Jersey
MWM
168
Moran Wealth Management
Florida
Public Employees Retirement Association of Colorado
169
Public Employees Retirement Association of Colorado
Colorado
EGM
170
Engineers Gate Manager
New York
HNB
171
Huntington National Bank
Ohio
JMPWA
172
JP Morgan Private Wealth Advisors
California
Wolverine Trading
173
Wolverine Trading
Illinois
Ameriprise
174
Ameriprise
Minnesota
MAM
175
Martingale Asset Management
Massachusetts